ON DEMAND

BioPharma Dive Live

The Outlook for Biotech in 2023

Featuring

Jeff Jonas

CEO
ABIO-X

Jeremy Levin

Chairman and CEO
Ovid Therapeutics 

Chris Newman

Editor
BioPharma Dive

Greg Verdine

Founder and CEO
LifeMine Therapeutics and FogPharma

CTA



After a historic downturn, what's in store for the biotech sector in 2023?

Join BioPharma Dive and a panel of industry experts to discuss their outlook for the industry and the potential catalysts they're watching.

  • Will pharmaceutical companies take a more active role in dealmaking?
  • What clinical trial readouts could shape R&D investments?
  • Will demand for IPOs bounce back?

We'll debate these topics as well as questions from the audience.

Watch Now

Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor

Session Information

Itaque earum rerum hic tenetur

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Nam libero tempore

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Et harum quidem rerum facilis

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.